Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology | Infections and Infectious Diseases | Family Medicine
Disease Category: Irritable Bowel Syndrome (IBS)
Location: United States, FL
Study to Evaluate the Efficacy, Safety, and Tolerability of XXXX in the Treatment Irritable Bowel Syndrome with Diarrhea
Title: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of XXXX in the Treatment of Patients With Diarrhea- Predominant Irritable Bowel Syndrome.
Patient Inclusion Criteria:
To be eligible for enrollment in this study, each of e following
criteria must be satisfied with a “YES” answer (unless not applicable):
Patient Exclusion Criteria:
To be eligible for this study, each of the following criteria must be satisfied with a “NO” answer:
CW ID: 182134
Date Last Changed:
July 18, 2013
Sue Lofald, Clinical Research CoordinatorIMA Research3901 University Blvd, South
Suite 203Jacksonville, FL 32216Phone: 866-879-2507Fax: 866-777-8019
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.